DDX60 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.104600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.751600E-01
Normal-vs-Stage2
6.995400E-01
Normal-vs-Stage3
5.553800E-01
Normal-vs-Stage4
7.027800E-01
Stage1-vs-Stage2
4.076000E-01
Stage1-vs-Stage3
6.760200E-01
Stage1-vs-Stage4
4.474200E-01
Stage2-vs-Stage3
3.321400E-01
Stage2-vs-Stage4
9.384800E-01
Stage3-vs-Stage4
3.773200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.523000E-01
Normal-vs-AfricanAmerican
9.807600E-01
Normal-vs-Asian
6.029200E-01
Caucasian-vs-AfricanAmerican
8.092200E-01
Caucasian-vs-Asian
3.720400E-01
AfricanAmerican-vs-Asian
3.629800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.210000E-01
Normal-vs-Female
8.060800E-01
Male-vs-Female
9.021400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.683200E-01
Normal-vs-Age(41-60Yrs)
7.644400E-01
Normal-vs-Age(61-80Yrs)
8.047200E-01
Normal-vs-Age(81-100Yrs)
7.387000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.355600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.590400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.757800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.766400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.551200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.704180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.802800E-01
Normal-vs-Daily Drinker
7.896200E-01
Normal-vs-Weekly Drinker
8.232200E-01
Normal-vs-Occasional Drinker
8.574000E-01
Normal-vs-Social Drinker
7.895200E-01
Non Drinker-vs-Daily Drinker
2.080800E-01
Non Drinker-vs-Weekly Drinker
3.734600E-01
Non Drinker-vs-Occasional Drinker
3.480800E-01
Non Drinker-vs-Social Drinker
1.885010E-01
Daily Drinker-vs-Weekly Drinker
9.940600E-01
Daily Drinker-vs-Occasional Drinker
8.928000E-01
Daily Drinker-vs-Social Drinker
8.457000E-01
Weekly Drinker-vs-Occasional Drinker
9.070600E-01
Weekly Drinker-vs-Social Drinker
8.690400E-01
Occasional Drinker-vs-Social Drinker
9.671200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.115380E-01
Normal-vs-Grade 2
9.060400E-02
Normal-vs-Grade 3
2.959900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.68942999999588E-05
Grade 1-vs-Grade 3
1.63574999999527E-05
Grade 1-vs-Grade 4
1.115380E-01
Grade 2-vs-Grade 3
7.305800E-01
Grade 2-vs-Grade 4
9.060400E-02
Grade 3-vs-Grade 4
2.959900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.266600E-01
Normal-vs-NonDiabetic
7.993000E-01
Diabetic-vs-NonDiabetic
2.821600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.054400E-01
Normal-vs-NoPancreatitis
8.505400E-01
Pancreatitis-vs-NoPancreatitis
8.585400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.777000E-01
Normal-vs-N1
6.741600E-01
N0-vs-N1
7.216100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.814800E-01
Normal-vs-TP53-NonMutant
9.653600E-01
TP53-Mutant-vs-TP53-NonMutant
2.21459999999452E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
